Sonoma Pharmaceuticals, Inc., often recognized by its stock symbol SNOA, is a prominent player in the global healthcare industry. The company specializes in the development, manufacturing, and distribution of stabilized hypochlorous acid (HOCl) products. These products are designed to provide safe and effective solutions for a wide range of applications, including wound care, eye care, oral care, dermatological conditions, podiatry, animal health care, and non-toxic disinfectants. Sonoma Pharmaceuticals' primary business activities revolve around...
| S.No. | Ticker | Company | Market Cap | P/E | P/S | Total Debt (Qtr) |
|---|---|---|---|---|---|---|
| 1 | TAK | Takeda Pharmaceutical Co Ltd | 202.50 Bn | 40.69 | 6.74 | 27.43 Bn |
| 2 | ZTS | Zoetis Inc. | 51.58 Bn | 19.29 | 5.45 | 9.04 Bn |
| 3 | TEVA | Teva Pharmaceutical Industries Ltd | 32.45 Bn | 22.85 | 1.88 | 16.81 Bn |
| 4 | UTHR | UNITED THERAPEUTICS Corp | 26.06 Bn | 19.51 | 8.19 | - |
| 5 | ACB | Aurora Cannabis Inc | 15.01 Bn | 93.81 | -2,482.90 | 0.04 Bn |
| 6 | NBIX | Neurocrine Biosciences Inc | 12.80 Bn | 26.69 | 4.47 | - |
| 7 | HCM | HUTCHMED (China) Ltd | 12.21 Bn | 26.85 | 22.27 | 0.09 Bn |
| 8 | ELAN | Elanco Animal Health Inc | 11.64 Bn | -49.87 | 2.47 | 4.02 Bn |